Sutro Biopharma
STRO
STRO
113 hedge funds and large institutions have $280M invested in Sutro Biopharma in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1.6% less ownership
Funds ownership: 98.18% → 96.58% (-1.6%)
Holders
113
Holding in Top 10
1
Calls
$191K
Puts
–
Top Buyers
| 1 | +$9.64M | |
| 2 | +$3.95M | |
| 3 | +$2.94M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$2.79M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.77M |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$1.74M | |
| 3 | -$1.52M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.5M |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$1.31M |